🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study focuses on the evaluation of low doses (600 and 1200 mg) and sho...
Status
Completed
Location
Hospital Clinic
Start Date
2017-11-13
Trial ID
NCT03587766
Treatments Being Tested
The aim of the study is to assess the efficacy and safety of an oral regime...
Status
Completed
Location
Multiple Locations
Start Date
2014-05-03
Trial ID
NCT02184689
Treatments Being Tested
This study is designed to determine the efficacy of Fexinidazole as an oral...
Status
Terminated
Location
Doka Hospital
Start Date
2013-11
Trial ID
NCT01980199
Treatments Being Tested
The present study is designed to assess the impact of concomitant food inta...
Status
Completed
Location
SGS Aster s.a.s.
Start Date
2011-02
Trial ID
NCT01340157
Treatments Being Tested
Phase 1 bioequivalence (BE) study. This study is for regulatory purpose to ...
Status
Completed
Location
Biotrial
Start Date
2015-03
Trial ID
NCT02571062
Treatments Being Tested
In human, metabolic hepatic clearance represents a significant part of the ...
Status
Completed
Location
Investigational Site Number: 100-0001
Start Date
2023-01-18
Trial ID
NCT05607173
Treatments Being Tested
The ultimate goal of this study is to show that fexinidazole offers an alte...
Status
Completed
Location
Rumphi District Hospital
Start Date
2019-09-29
Trial ID
NCT03974178
Treatments Being Tested
This study evaluates the effectiveness of fexinidazole administered to pati...
Status
Completed
Location
Dipumba Hospital
Start Date
2016-11-10
Trial ID
NCT03025789
Treatments Being Tested
This trial will study the tolerability and pharmacokinetic of fexinidazole ...
Status
Terminated
Location
SGS Life Sciences
Start Date
2011-09
Trial ID
NCT01483170
Treatments Being Tested
Human African Trypanosomiasis (HAT), or sleeping sickness, is one of the pa...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-01-01
Trial ID
NCT05645822
Treatments Being Tested